- The impact of the new UK clinical trial regulations coming into force in April 2026 and what they mean for sponsors, investigators, and trial delivery
- Government priorities and progress across the UK clinical research ecosystem two years on
- How artificial intelligence is transforming clinical trial design, feasibility, patient identification, and operational efficiency
- Cross-sector collaboration between regulators, industry, and the NHS to strengthen the UK’s position as a leading destination for clinical research
- Looking ahead: building a more agile, technology-enabled clinical trials environment in the UK
- Innovation & Industry Presence
- Collaboration Ecosystem
- Connectivity & Talent
- Future Growth & Investment
- Prioritising evidence that meaningfully advances regulatory and clinical credibility
- Leveraging publications, partnerships and existing data without inflating costs
- Practical tips and insights on structuring FDA interactions and study design to maximise impact with constrained resources
